Price: 6.75

Today's Change: 0.04

Today's Percent Change: 0.83%

Today's Volume: 0

Average Daily Volume: 27150

52 week low: 2.67

52 week high: 7.39

Market cap: 232550000.0

EBITDA: 4410000.0

EBITDA / market_cap: 1.90%

Earnings per Share (EPS): 0.04

EPS / price: 0.59%

Dividend Yield: 0.0%

Dividend per share: 0.0

Book value: 2.32

Price to Book Ratio: 2.89

Price to Earnings (P/E) Ratio: 160.71

Price to Earnings Growth (PEG) Ratio: 0.0

Price to Sales (P/S) Ratio: 2.67

Short Ratio: 32.7

Exchange: "PNK"

Short term: UP (Previous: DOWN)

Mid term: UP (Previous: DOWN)

Long term: UP (Previous: UP)

Support: 3.12

Resistance: 3.28

Pivot point: 3.19

SMA 10: 4.38

SMA 50: 5.26

SMA 100: 5.27

RSI 10: 21.29

RSI 50: 38.04

RSI 100: 43.40

EMA 10: 4.72

EMA 50: 5.28

EMA 100: 5.27


Based on 13 buy signals and 0 sell signals

Previous signal: strong buy




@thefinreviewer: Aerpio Pharmaceuticals Inc. $OSIR Comparison side by side

@thefinreviewer: Puma Biotechnology Inc. $OSIR

@tradnews_: RT @SwingTradeBot: On our Top 50 Bullish List today: $SWM $PARR $SRE $TMK $CHRS $ERIE $ANGO $NGL $NVS $OSIR ...

@AlertTrade: RT @SwingTradeBot: On our Top 50 Bullish List today: $SWM $PARR $SRE $TMK $CHRS $ERIE $ANGO $NGL $NVS $OSIR ...

@SwingTradeBot: On our Top 50 Bullish List today: $SWM $PARR $SRE $TMK $CHRS $ERIE $ANGO $NGL $NVS $OSIR ...

@DrTranBioSci: IBI M&A Series: What's Next After Osiris? $OSIR $SNN $VCEL $BLFS

@mmahotstuff1: Can Osiris Therapeutics Inc $OSIR’s Tomorrow Be Different? The Stock Had Decline in Shorts

@bibeypost_stock: Osiris Therapeutics Inc $OSIR’s Trend Up, Especially After Decreased Shorts

@bibeypost_stock: Osiris Therapeutics Inc $OSIR Quarterly Sentiment Report

@thefinreviewer: Denali Therapeutics Inc. $OSIR

@DrTranBioSci: IBI NDC: Strong Catalysts Brewing In Osiris And Progenics $OSIR $PGNX

@BlogYomi: Reviewing Sangamo Therapeutics Inc. $OSIR's results

@BlogYomi: Outlook Therapeutics Inc. $OSIR

@BlogYomi: Reviewing Bellerophon Therapeutics Inc. $OSIR's results

@HottestStockNow: Law Firm Investigating $OSIR